Physician profile
Chad Morley
NPI 1033485347
$5,601.34
in general payments reported to CMS, 2019-2025
13 companies · $545 in 2025
The $545 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $520 · 2020: $226 · 2021: $434 · 2022: $680 · 2023: $2,750 · 2024: $448 · 2025: $545.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $1,707 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $1,707.13 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,433.30 | 2019-2025 | Lithovue, Lithovue Elite, Ams 800 Artificial Urinary Sphincter |
| Medtronic, INC. | $368.29 | 2021-2025 | Interstim |
| Olympus America INC. | $216.59 | 2022-2025 | Itind System |
| Coloplast Corp | $94.33 | 2022 | |
| Medtronic USA, INC. | $82.75 | 2019-2020 | |
| Ethicon US, LLC | $72.84 | 2022 | |
| Stryker Corporation | $71.43 | 2024 | 1788 |
| Coopersurgical, INC. | $68.15 | 2023 | Endosee |
| Janssen Scientific Affairs, LLC | $62.90 | 2025 | |
| Rochester Medical Corporation | $60.57 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Teleflex LLC | $22.70 | 2022 | |
| Seagen INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Morley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.